Marco A. Biamonte, Founder and Chief Executive Officer. Marco holds a Ph.D. in organic chemistry from the University of Cambridge, UK, and performed post-doctoral studies at the Swiss Institute for Technology (ETH-Z). Marco worked as a medicinal chemist in the pharmaceutical industry for 14 years, mostly in oncology. He co-led up to 3 projects simultaneously in 3 different therapeutic areas and managed up to 12 chemists. He and his colleagues have had success in advancing 2 new drugs into clinical trials (BIIB-021 and BIIB-028, respectively in Phase II and Phase I). In 2011, motivated by a long-standing desire, Marco created DDTD.
Dr. Valerie Pasquetto, PhD, PMP, Vice President of Operations. Valerie, holds a Ph.D. in immunology from the Pasteur Institute, Paris, and performed her post-doctoral work at the Scripps Research Institute, San Diego. For the past 18 years Valerie has worked in both non-profit and industrial settings (Novartis) mostly in the field of infectious diseases. She managed several research and development platforms in different therapeutic areas, including the implementation of a biorepository bank, and the development of bioassays and vaccine adjuvants. Valerie is a certified project manager professional (PMP) since 2010.
Bijan Pedram, Sr. Scientist. Bijan graduated from the University of Toronto with a M.S. in Organic Chemistry. He has more than 20 years of experience in medicinal chemistry and industrial process development in multiple disease areas including oncology, inflammation, anemia, osteoporosis, and infectious diseases. He participated to the advancement of 4 new drugs into clinical trials. Prior to joining DDTD Bijan worked at Ligand Pharmaceuticals, Celgene, Vertex, and Inception Sciences. At DDTD, Bijan was instrumental in the development of several nanoparticle-based lateral flow assays, including DDTD’s lead product, the Loa Antibody Rapid Test.
Melissa Chalmers, Sr. Director of Philanthropy. Melissa holds a double BBA in Finance and Economics from the University of Oklahoma and a Masters in Business Administration from Colorado State University. She started her career in investment banking and then later moved to the field of monetization. She has worked with for profit and nonprofit companies for the past 14 years helping to grow overall revenue and income streams. At DDTD, Melissa is in charge of all fundraising efforts, including collaboration on grant writing and requests, donor cultivation and stewardship, and special event planning and execution.
Maria Gonzalez, Sr. Scientist. Maria holds a Ph.D. in Organic/Physical Chemistry from the University of Vigo, Spain, and worked as a post-doctoral fellow in the Laboratory of Medicinal Chemistry at the National Cancer Institute-NIH in Frederick, and at the Biodesign Institute, Arizona State University, in Arizona. Her expertise lies in the development of new tools involving nanotechnology and different types of immunoassays. Prior to joining DDTD she worked as an assay development scientist of quantitative immunoassays. At DDTD, Maria works in the development of several nanoparticle-based lateral flow assays, including collaborations with Janssen Diagnostics and nanoComposix.